NRXP holders · CITADEL ADVISORS LLC 13F · NRXP stock

CITADEL ADVISORS LLC NRX Pharmaceuticals Inc (NRXP) 13F holding

CITADEL ADVISORS LLC reported 24,700 NRXP shares valued at $52.6M as of 2026-03-31 (COM NEW), Call. Cached 13F row, not a live tape.

Cached NRXP reports from CITADEL ADVISORS LLC
ReportSharesValueClass
2026-03-3124,700$52.6MCall
2025-12-3135,800$97.0MCall
2025-09-3032,900$108.6MCall
2025-06-3092,361$301.1MCOM NEW

Not investment advice. Cached 13F row, not EDGAR XML.